Czech Republic wants to regulate, rather than ban, synthetic cannabinoids made from CBD

The Ministry of Health of the Czech Republic has announced its decision to regulate, rather than ban, the production of synthetic compounds derived from CBD from hemp, which are likely to generate psychotropic effects. Initially, those responsible for food safety proposed a complete ban on these products. However, the government now intends to establish clear guidelines for its sale and control.

The Czech Parliament is currently considering an amendment proposal that imposes restrictions on substances such as HHC (hexahydrocannabinol) and other synthetic psychoactive products. Key regulations provide that these products are only sold to individuals aged 18 or over, under the supervision of a salesperson (not in vending machines) and with a ban on advertising.

One of the focus areas of the regulation is lab-produced CBD-based compounds that mimic the “high” felt when consuming cannabis. These products are created through laboratory processes that involve CBD and its manipulation, in order to create new compounds. The emergence of HHC initially led to concerns that CBD itself would be banned in the Czech Republic, but the government ended up abandoning this position.

Earlier this year, the Czech Republic was among 20 EU countries where HHC products were readily available, prompting health warnings from the European Monitoring Center for Drugs and Drug Addiction. In March, the Czech government issued warnings about HHC, warning consumers against using these products due to potential health risks.

O Czech Pirate Party (Pirátská Strana), one of the supporters of the proposed amendment, says that a pure and simple ban is not the solution. Instead, they emphasize the need for greater protection for young and adult consumers. Rather than seeking a ban, the focus will be on implementing robust safeguards for users.

As the Czech Republic seeks to strike a balance between regulation and freedom of choice, the proposed amendment aims to ensure the responsible use of synthetic CBD derivatives and other psychoactive substances. With a focus on consumer safety and adherence to clear guidelines, the government hopes to create an environment that protects individuals while allowing informed decisions regarding these products.